Company news
Haemonetics Corporation (NYSE:HAE) news
Every Haemonetics Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
August 3, 2026
Martin Madaus Elected to Haemonetics Board of Directors
July 28, 2026
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026
July 8, 2026
Haemonetics Updates Financial Reporting Segments
June 5, 2026
Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
May 7, 2026
Haemonetics to Present at Bank of America 2026 Healthcare Conference
May 5, 2026
New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
April 24, 2026
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
April 1, 2026
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
March 30, 2026
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
February 23, 2026
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
February 20, 2026
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
February 5, 2026
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
January 12, 2026
Vivasure Medical Announces Acquisition by Haemonetics Corporation
January 9, 2026
Haemonetics Acquires Vivasure Medical Limited
January 9, 2026
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
January 7, 2026
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
January 2, 2026
UPDATE Headwall Appoints Tim Spang as Chief Executive Officer
November 13, 2025
Headwall Appoints Tim Spang as Chief Executive Officer
November 13, 2025
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
November 6, 2025
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025
October 9, 2025
Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website
August 7, 2025
Integer Appoints Michael Coyle to Board of Directors
July 10, 2025
Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2026 Results: August 7, 2025
July 9, 2025
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
May 30, 2025
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website
May 8, 2025
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025
March 31, 2025
Haemonetics Announces Executive Leadership Updates
March 3, 2025
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference
February 24, 2025